July 27 (Reuters) - The U.S. FDA has approved Freenome's (FRNM.O), opens new tab blood-based colorectal cancer screening test for older adults, paving the way for partner ‌Abbott (ABT.N), opens new ...

Washington — A blood test may predict if apparently healthy older adults are likely to develop Alzheimer's symptoms in the next five or 10 years, researchers reported Wednesday. That information could ...

Cognitively healthy older adults with high levels of a biomarker called p-tau217 in their blood had an estimated 38% greater chance of developing early signs of dementia over five years, a new study ...

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri ...

For the first time, a blood test has been added to the list of the American Cancer Society’s recommended screenings for colorectal cancer. It’s not meant to replace colonoscopies, aiming instead at ...

An integrated suite of bioassays provides a coherent workflow to track antibody Fc effector activity across every stage of mAb drug development Potency assays that fail during tech transfer or ...

Abstract: This paper proposes a disposable strip type biosensor for urine urea assay which is integrable to electronic circuitry designed for the Point-of-Care (PoC) application. The sensor is cheap, ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...